Mayo Clinic is taking epilepsy research in a bold new direction, exploring treatment approaches to help patients living with the most severe and difficult-to-treat forms of epilepsy. Neurosurgeon Jonathon J. Parker, M.D., Ph.D., is the lead investigator of the first-in-human clinical trial at Mayo Clinic studying the use of implanted specialized inhibitory brain cells as a potential reparative treatment for drug-resistant epilepsy (DRE). The clinical trial is underway at Mayo Clinic in Arizona.

Experts break down the essentials of epilepsy. What it is, how to talk about it, and how to live well with it. | Healthline